NO20051303L - Nye benzoimidazolderivater nyttige som antiproliferative midler - Google Patents
Nye benzoimidazolderivater nyttige som antiproliferative midlerInfo
- Publication number
- NO20051303L NO20051303L NO20051303A NO20051303A NO20051303L NO 20051303 L NO20051303 L NO 20051303L NO 20051303 A NO20051303 A NO 20051303A NO 20051303 A NO20051303 A NO 20051303A NO 20051303 L NO20051303 L NO 20051303L
- Authority
- NO
- Norway
- Prior art keywords
- new
- formula
- derivatives useful
- compounds
- antiproliferative agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40652402P | 2002-08-28 | 2002-08-28 | |
US41704702P | 2002-10-08 | 2002-10-08 | |
PCT/IB2003/003634 WO2004020431A2 (en) | 2002-08-28 | 2003-08-14 | Novel benzoimidazole derivatives useful as antiproliferative agents |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20051303L true NO20051303L (no) | 2005-05-18 |
Family
ID=31981411
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20051303A NO20051303L (no) | 2002-08-28 | 2005-03-14 | Nye benzoimidazolderivater nyttige som antiproliferative midler |
Country Status (41)
Country | Link |
---|---|
US (1) | US7071337B2 (pt) |
EP (1) | EP1594858B1 (pt) |
JP (1) | JP4551771B2 (pt) |
KR (2) | KR20070086768A (pt) |
CN (1) | CN1319966C (pt) |
AP (1) | AP2005003237A0 (pt) |
AR (1) | AR041055A1 (pt) |
AT (1) | ATE445610T1 (pt) |
AU (1) | AU2003250499B2 (pt) |
BR (1) | BRPI0313942C1 (pt) |
CA (1) | CA2495577C (pt) |
CR (1) | CR7698A (pt) |
CU (1) | CU23413B7 (pt) |
CY (1) | CY1110580T1 (pt) |
DE (1) | DE60329715D1 (pt) |
DK (1) | DK1594858T3 (pt) |
DO (1) | DOP2003000694A (pt) |
EA (1) | EA008448B1 (pt) |
EC (1) | ECSP055633A (pt) |
ES (1) | ES2333219T3 (pt) |
GE (1) | GEP20064005B (pt) |
HK (1) | HK1078571A1 (pt) |
HN (1) | HN2003000257A (pt) |
HR (1) | HRP20050191B1 (pt) |
IL (1) | IL166832A (pt) |
IS (1) | IS2738B (pt) |
MA (1) | MA27389A1 (pt) |
MX (1) | MXPA05001256A (pt) |
MY (1) | MY139357A (pt) |
NO (1) | NO20051303L (pt) |
NZ (1) | NZ538427A (pt) |
OA (1) | OA12916A (pt) |
PA (1) | PA8580301A1 (pt) |
PE (1) | PE20050131A1 (pt) |
PL (1) | PL377678A1 (pt) |
PT (1) | PT1594858E (pt) |
RS (1) | RS20050180A (pt) |
SI (1) | SI1594858T1 (pt) |
TW (1) | TW200407131A (pt) |
UY (1) | UY27952A1 (pt) |
WO (1) | WO2004020431A2 (pt) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2323214C2 (ru) * | 2003-06-24 | 2008-04-27 | Пфайзер Продактс Инк. | Способы получения производных 1-[2-(бензимидазол-1-ил)хинолин-8-ил]пиперидин-4-иламина |
BRPI0509580A (pt) * | 2004-03-30 | 2007-11-27 | Pfizer Prod Inc | combinações de inibidores de transdução de sinal |
GB0411421D0 (en) * | 2004-05-21 | 2004-06-23 | Glaxo Group Ltd | Novel compounds |
WO2006038111A1 (en) * | 2004-10-07 | 2006-04-13 | Pfizer Products Inc. | Benzoimidazole derivatives useful as antiproliferative agents |
KR101193797B1 (ko) | 2005-04-26 | 2012-10-23 | 화이자 인코포레이티드 | P-카드헤린 항체 |
CA2621371C (en) | 2005-09-07 | 2018-05-15 | Amgen Fremont Inc. | Human monoclonal antibodies to activin receptor-like kinase-1 |
EA200802058A1 (ru) | 2006-05-09 | 2009-06-30 | Пфайзер Продактс Инк. | Производные циклоалкиламинокислот и их фармацевтические композиции |
WO2008124323A1 (en) | 2007-04-03 | 2008-10-16 | Array Biopharma Inc. | Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors |
BRPI0912882A2 (pt) * | 2008-05-21 | 2017-05-16 | Incyte Corp | sais de 2-flúor-n-metil-4-[7-(quinolin-6-il-metil)-imidazo[1,2-b][1,2,4]triazin-2-il]benzamida e processos relacionados à preparação dos mesmos |
US10420665B2 (en) | 2010-06-13 | 2019-09-24 | W. L. Gore & Associates, Inc. | Intragastric device for treating obesity |
US9526648B2 (en) | 2010-06-13 | 2016-12-27 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US8628554B2 (en) | 2010-06-13 | 2014-01-14 | Virender K. Sharma | Intragastric device for treating obesity |
US10010439B2 (en) | 2010-06-13 | 2018-07-03 | Synerz Medical, Inc. | Intragastric device for treating obesity |
AU2011297961B2 (en) | 2010-09-02 | 2015-07-02 | Merck Patent Gmbh | Pyrazolopyridinone derivatives as LPA receptor antagonists |
GB201103578D0 (en) | 2011-03-02 | 2011-04-13 | Sabrepharm Ltd | Dipyridinium derivatives |
KR101738063B1 (ko) | 2012-09-21 | 2017-05-19 | 아로그 파마슈티칼스, 인코퍼레이티드 | 구조적으로 활성인 인산화된 flt3 키나제의 억제 방법 |
US11642340B2 (en) | 2012-09-26 | 2023-05-09 | Arog Pharmaceuticals, Inc. | Method of inhibiting mutant C-KIT |
US10835525B2 (en) | 2012-09-26 | 2020-11-17 | Arog Pharmaceuticals, Inc. | Method of inhibiting mutant C-KIT |
TWI599356B (zh) * | 2012-09-26 | 2017-09-21 | 安羅格製藥有限責任公司 | 抑制突變型c-kit的方法 |
BR112015016282A2 (pt) | 2013-01-07 | 2017-07-11 | Arog Pharmaceuticals Inc | crenolanibe para tratamento de distúrbios proliferativos de flt3 mutado |
US10463658B2 (en) | 2013-10-25 | 2019-11-05 | Videra Pharmaceuticals, Llc | Method of inhibiting FLT3 kinase |
KR102548547B1 (ko) * | 2014-10-31 | 2023-06-27 | 제노사이언스 파마 | 신규한 항암제로서의 치환 2,4 디아미노-퀴놀린 |
GB2543550A (en) | 2015-10-21 | 2017-04-26 | Hox Therapeutics Ltd | Peptides |
US10779980B2 (en) | 2016-04-27 | 2020-09-22 | Synerz Medical, Inc. | Intragastric device for treating obesity |
WO2017191599A1 (en) * | 2016-05-04 | 2017-11-09 | Genoscience Pharma | Substituted 2, 4-diamino-quinoline derivatives for use in the treatment of proliferative diseases |
US11078541B2 (en) | 2016-11-02 | 2021-08-03 | Arog Pharmaceuticals, Inc. | Crenolanib for treating FLT3 mutated proliferative disorders associated mutations |
CN107382983B (zh) * | 2017-08-24 | 2020-08-07 | 扬州市三药制药有限公司 | 一种治疗白血病药物的合成方法 |
CN107382984B (zh) * | 2017-08-24 | 2020-07-10 | 扬州市三药制药有限公司 | 一种治疗白血病药物的制备方法 |
CN110840893A (zh) | 2018-12-13 | 2020-02-28 | 安罗格制药有限责任公司 | 含克莱拉尼的药物组合物及其用途 |
US11471451B2 (en) | 2019-08-19 | 2022-10-18 | Arog Pharmaceuticals, Inc. | Uses of crenolanib |
CN113024435B (zh) * | 2019-12-09 | 2022-06-17 | 苏州恩华生物医药科技有限公司 | 连双环结构sigma-1受体抑制剂 |
WO2022019998A1 (en) * | 2020-07-20 | 2022-01-27 | Arog Pharmaceuticals, Inc. | Crystal forms of crenolanib and methods of use thereof |
EP4192459A1 (en) * | 2020-08-05 | 2023-06-14 | The General Hospital Corporation | Salt inducible kinase inhibitors |
US11524006B2 (en) | 2020-09-17 | 2022-12-13 | Arog Pharmaceuticals, Inc. | Crenolanib for treating TRK kinase associated proliferative disorders |
US11969420B2 (en) | 2020-10-30 | 2024-04-30 | Arog Pharmaceuticals, Inc. | Combination therapy of crenolanib and apoptosis pathway agents for the treatment of proliferative disorders |
CN113683594B (zh) * | 2021-09-07 | 2022-12-27 | 曲靖师范学院 | 一种喹啉-苯并咪唑盐类化合物及其合成方法和应用 |
JP2023063189A (ja) | 2021-10-22 | 2023-05-09 | アログ・ファーマシューティカルズ・インコーポレイテッド | 以前の治療に対して再発性/不応性のflt3突然変異増殖性障害を治療するためのクレノラニブ |
WO2023081923A1 (en) | 2021-11-08 | 2023-05-11 | Frequency Therapeutics, Inc. | Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof |
CN114409632B (zh) * | 2022-02-22 | 2024-04-30 | 北京鲲达宇科技有限公司 | 2-取代氨基-3-苯并咪唑取代的喹啉衍生物及其制备方法与应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8607683D0 (en) | 1986-03-27 | 1986-04-30 | Ici Plc | Anti-tumor agents |
US5990146A (en) | 1997-08-20 | 1999-11-23 | Warner-Lambert Company | Benzimidazoles for inhibiting protein tyrosine kinase mediated cellular proliferation |
CA2303830A1 (en) | 1997-09-26 | 1999-04-08 | Merck & Co., Inc. | Novel angiogenesis inhibitors |
AU784589B2 (en) * | 1999-11-30 | 2006-05-04 | Board Of Trustees Of The Leland Stanford Junior University | Bryostatin analogues, synthetic methods and uses |
UA75055C2 (uk) * | 1999-11-30 | 2006-03-15 | Пфайзер Продактс Інк. | Похідні бензоімідазолу, що використовуються як антипроліферативний засіб, фармацевтична композиція на їх основі |
JP2008002005A (ja) * | 2006-06-21 | 2008-01-10 | Shimada Shoji Kk | 衣服用パッド |
-
2003
- 2003-08-12 PA PA8580301A patent/PA8580301A1/es unknown
- 2003-08-14 ES ES03791110T patent/ES2333219T3/es not_active Expired - Lifetime
- 2003-08-14 WO PCT/IB2003/003634 patent/WO2004020431A2/en active Application Filing
- 2003-08-14 BR BRPI0313942A patent/BRPI0313942C1/pt not_active IP Right Cessation
- 2003-08-14 AU AU2003250499A patent/AU2003250499B2/en not_active Ceased
- 2003-08-14 OA OA1200500059A patent/OA12916A/en unknown
- 2003-08-14 JP JP2004569727A patent/JP4551771B2/ja not_active Expired - Lifetime
- 2003-08-14 PL PL37767803A patent/PL377678A1/pl not_active Application Discontinuation
- 2003-08-14 EA EA200500174A patent/EA008448B1/ru not_active IP Right Cessation
- 2003-08-14 CA CA 2495577 patent/CA2495577C/en not_active Expired - Lifetime
- 2003-08-14 DE DE60329715T patent/DE60329715D1/de not_active Expired - Lifetime
- 2003-08-14 SI SI200331687T patent/SI1594858T1/sl unknown
- 2003-08-14 AT AT03791110T patent/ATE445610T1/de active
- 2003-08-14 AP AP2005003237A patent/AP2005003237A0/xx unknown
- 2003-08-14 DK DK03791110T patent/DK1594858T3/da active
- 2003-08-14 KR KR1020077014809A patent/KR20070086768A/ko not_active Application Discontinuation
- 2003-08-14 PT PT03791110T patent/PT1594858E/pt unknown
- 2003-08-14 NZ NZ538427A patent/NZ538427A/en not_active IP Right Cessation
- 2003-08-14 KR KR20057003493A patent/KR100816166B1/ko active IP Right Grant
- 2003-08-14 GE GEAU2003008665 patent/GEP20064005B/en unknown
- 2003-08-14 MX MXPA05001256A patent/MXPA05001256A/es active IP Right Grant
- 2003-08-14 CN CNB038206218A patent/CN1319966C/zh not_active Expired - Lifetime
- 2003-08-14 EP EP20030791110 patent/EP1594858B1/en not_active Expired - Lifetime
- 2003-08-19 DO DO2003000694A patent/DOP2003000694A/es unknown
- 2003-08-25 PE PE2003000864A patent/PE20050131A1/es active IP Right Grant
- 2003-08-25 HN HN2003000257A patent/HN2003000257A/es unknown
- 2003-08-26 MY MYPI20033225 patent/MY139357A/en unknown
- 2003-08-26 US US10/648,151 patent/US7071337B2/en active Active
- 2003-08-26 UY UY27952A patent/UY27952A1/es not_active Application Discontinuation
- 2003-08-26 AR ARP030103073 patent/AR041055A1/es unknown
- 2003-08-27 TW TW92123585A patent/TW200407131A/zh unknown
-
2005
- 2005-01-20 IS IS7660A patent/IS2738B/is unknown
- 2005-02-10 IL IL166832A patent/IL166832A/en active IP Right Grant
- 2005-02-14 CU CU20050031A patent/CU23413B7/es not_active IP Right Cessation
- 2005-02-22 CR CR7698A patent/CR7698A/es unknown
- 2005-02-28 MA MA28124A patent/MA27389A1/fr unknown
- 2005-02-28 EC ECSP055633 patent/ECSP055633A/es unknown
- 2005-02-28 HR HRP20050191AA patent/HRP20050191B1/hr not_active IP Right Cessation
- 2005-03-14 NO NO20051303A patent/NO20051303L/no not_active Application Discontinuation
- 2005-08-14 RS YUP-2005/0180A patent/RS20050180A/sr unknown
- 2005-11-18 HK HK05110348A patent/HK1078571A1/xx not_active IP Right Cessation
-
2009
- 2009-11-30 CY CY20091101249T patent/CY1110580T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20051303L (no) | Nye benzoimidazolderivater nyttige som antiproliferative midler | |
NO20053483L (no) | 4-Anilinokinazolinderivater for behandling av unormal cellevekst | |
NO20055143L (no) | Doseringsformer innbefattende AG013736 | |
AP1895A (en) | Novel benzoimidazole derivatives useful as antiproliferative agents. | |
DK1029853T3 (da) | Heteroaromatiske bicykliske derivativer, der er egnede som anticancermidler | |
MXPA05006420A (es) | Derivados de pirimidina para el tratamiento de crecimiento celular anormal. | |
NO20045103L (no) | Benzofuserte heteroarylamid-derivater av thienopyridiner anvendelige som terapeutiske midler, farmasoytiske blandinger omfattende de samme og fremgangsmater for deres anvendelse | |
NO20050016L (no) | Difenylazetidinonderivater for behandling av forstyrrelser i lipid metabolismen | |
YU95102A (sh) | Supstituisani biciklični derivati u lečenju abnormalnog rasta ćelija | |
DE69923849D1 (de) | Quinolin-2-on-derivate verwendbar als antikrebsmittel | |
NO20015172L (no) | 1-metyl-erytromycin-derivater | |
BRPI0413876A (pt) | tienopiridin-fenilacetamidas e seus derivados úteis como agentes antiangiogênicos | |
NO20076195L (no) | Nye 2-azetidinonderivater for behandling av hyperlipidemiske sykdommer | |
NO20076196L (no) | Nye 2-azetidinonderivater som kolesterolabsorpsjonsinhibitorer for behandling av hyperlipidemiske tilstander | |
WO2006067614A3 (en) | Heteroaromatic derivatives useful as anticancer agents | |
MY124390A (en) | Substituted bicyclic derivatives useful as anticancer agents | |
NO20085060L (no) | Triazolpyrazinderivater anvendelige som anti-cancermidler | |
MX2007004183A (es) | Derivados de benzoimidazol utiles como agentes antiproliferacion. | |
NO20052730L (no) | Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser | |
NO20064010L (no) | Indazolderivater og farmasoytiske preparater inneholdelse slike | |
NO20052182L (no) | Nye forbindelser | |
WO2005066167A3 (en) | 3-quinuclidinyl heteroatom bridged biaryl derivatives | |
WO2006129168A3 (en) | Bicyclic derivatives for the treatment of abnormal cell growth | |
NO20071319L (no) | Fremgangsmate for fremstilling av isotiazolderivater. | |
RS44004A (en) | Processes for the preparation of substituted bicyclid derivatives for the treatment of abnormal cell growth |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |